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Chondrosarcoma is the second most common primary malignant bone tumour. Distinguishing between grades is not necessarily
straightforward and may alter the disease management. We evaluated the correlation between histological grading of the
preoperative image-guided needle biopsy and the resection specimen of 78 consecutive cases of chondrosarcoma of the femur,
humerus, and tibia. In 11 instances, there was a discrepancy in histological grade between the biopsy and surgical specimen.
Therefore, there was an 85.9% (67/78) accuracy rate for pre-operative histological grading of chondrosarcoma, based on
needle biopsy. However, the accuracy of the diagnostic biopsy to distinguish low-grade from high-grade chondrosarcoma was
93.6% (73/78). We conclude that accurate image-guided biopsy is a very useful adjunct in determining histological grade
of chondrosarcoma and the subsequent treatment plan. At present, a multidisciplinary approach, comprising experienced
orthopaedic surgeons, radiologists, and pathologists, oﬀers the most reliable means of accurately diagnosing and grading of
chondrosarcoma of long bones.
1.Introduction
Chondrosarcoma is the second most common primary
malignant bone tumour, exceeded in frequency only by
osteosarcoma [1–6]. There are three well-recognised histo-
logicalgrades,whichmayinﬂuencethechoiceofappropriate
management [7]. Unfortunately, distinguishing between
grades from pre-operative image-guided biopsy is not nec-
essarily straightforward [8–13]. Choice of management in
such cases depends on a combination of history, clinical
examination, and radiological ﬁndings.
Histologically, chondrosarcomas may be classiﬁed into
three groups according to cellularity and pleomorphism
(I, II, and III) or may be referred to as dediﬀerentiated
chondrosarcomas [14]. Clinically, chondrosarcomas are sub-
divided into low grade (I) and high grade (II, III, and ded-
iﬀerentiated). Overall ﬁve-year survival has been reported
as 75% [15]. Low-grade lesions tend to be slow growing,
metastasise infrequently, and are associated with a 90% ﬁve-
year survival rate, which plateaus after this period [16]. They
are commonly treated by curettage with bone cement [17–
19], although some authors describe a high mortality risk
after intralesional resection (including curettage) in their
reports [6, 16]. High-grade tumours have a higher incidence
of metastasis, with a variably reported ﬁve-year survival rate
of 40%–80%for grades II-III, but signiﬁcantly inferior for
dediﬀerentiated tumours [7, 14]. This ﬁgures plateau’s at
approximately 20% survival beyond 10 years [16, 20]. Most2 International Journal of Surgical Oncology
are treated with wide excision (with the margins conﬁrmed
histologicallypostoperatively)andreconstruction[7,18,21].
The main aim of this study was to determine the
accuracy of pre-operative image-guided needle biopsy in
suspected chondrosarcoma of long bones, thus allowing an
evaluation of the reliability of image-guided needle biopsy
for planning surgical management. We restricted the study
to chondrosarcoma of the long bones given the relative ease
of obtaining an adequate biopsy sample from these locations
compared to those tumours located within the pelvis or
other parts of the axial skeleton. Furthermore, the treatment
options for such tumours may diﬀer signiﬁcantly from those
located in the long bones.
2.MaterialsandMethods
We retrospectively reviewed the tumour database at a
supraregional bone and soft tissue tumour unit. We exam-
inedtherecordsofallcasesofchondrosarcomadiagnosedon
needle biopsy, identifying 124 patients. Cases of chondrosar-
coma that did not undergo needle biopsy were excluded.
Cases where the biopsy was inconclusive (the rate at our
institution is 5.2% for all biopsies) or did not give a diag-
nosis of chondrosarcoma were not considered. We excluded
tumours not located within the femur, tibia, or humerus (31
pelvic/sacral, 5 forearm/hand, 4 rib, 3 shoulder, 2 sternum,
and 1 foot) leaving 78 patients with chondrosarcoma of
theselongbones.Allspecimenswereanalysedbyexperienced
dedicated musculoskeletal tumour Pathologists, with the
diagnosis and grade given by consensus opinion.
The mean age at presentation was 52 years old (range
10–87 years). The female-to-male ratio was 45 : 33. The
most common tumour location was the femur (n = 45),
followed by the humerus (n = 24) and tibia (n = 9). Stan-
dard radiological investigations included plain radiographs,
computed tomography (CT), whole-body bone scintigraphy
and magnetic resonance imaging (MRI). All of the tumours
were primary chondrosarcomas.
All patients underwent a pre-operative biopsy using a
Jamshidi needle, to assist planning of further management.
All biopsy approaches were preplanned following discussion
with referring surgeons and were performed by specialist
radiologists under ﬂuoroscopic or CT guidance. Following
departmental policy, all those graded as high grade from
the needle biopsy were surgically excised. Tumours graded
as low grade were treated either by curettage with bone
cement (mostly small, slow-growing, or peri-articular) or by
excision (large, rapidly growing or those tumours for which
resection and reconstruction was relatively straightforward)
dependant upon multidisciplinary discussion.
The histopathological diagnosis and grade were under-
takeninallcasesbyexperiencedmusculoskeletalpathologists
and were based on the light microscopic features according
to the World Health Organisation [22]. The histological
grade based on needle biopsy and surgical specimens was
compared by reviewing the histology reports. Where the
biopsy showed a mixed grade, the higher grade was taken as
the ﬁnal grading.
The research was performed following the Declaration of
Helsinki principles. Informed consent was obtained from all
research subjects.
3. Results
After exclusions, 78 long bone chondrosarcoma cases
remained. In 67 cases, there was agreement between the
needle biopsy histological grade and the ﬁnal histological
grade based on the resection specimen, giving an 86%
(67/78) accuracyrate for needle biopsy. In 11 instances, there
was a discrepancy in histological grade (Table 1) .I n9o f
these, the surgical histology revealed a higher grade than that
evident from the needle biopsy histology. In 2 cases, a higher
gradewasattributedtotheneedlebiopsyhistologycompared
to the surgical histology.
When considering the mismatch between clinically low-
grade and high-grade lesions, only 5 of the 11 cases
with a discrepancy in histological grade were diagnosed as
low grade on needle biopsy, but high grade on surgical
histology. Therefore, the accuracy of the diagnostic biopsy to
distinguish low-grade from high-grade chondrosarcoma was
94% (73/78).
4. Discussion
Chondrosarcoma comprises 10%–15% of all primary bone
tumours and can be deﬁned as a malignant tumour whose
cells produce hyaline cartilage, usually in a lobular growth
pattern. Despite a clear relationship between histological
grade and prognosis, the clinical course of chondrosarcoma
can be unpredictable [2, 4, 5, 16, 17, 23–25].
Needle biopsy is usually essential for the speciﬁc diag-
nosis of a bone lesion and will often allow an accurate
histological grade to be determined, thereby helping guide
further management. The literature indicates that the accu-
racy of histological grading from needle biopsies of bone
tumours in general is between 80% and 86% [8–10]. Lerma
et al. [26] report 85% concordance between cytology and
histology specimens from 39 cases of chondrosarcoma,
althoughKreicbergsetal.describethegreatestdiﬃcultyofall
bone tumours in diagnosing chondrosarcoma correctly [9].
In order to achieve this accuracy, precise image guidance is
required at the time of biopsy. An experienced pathologist
who is able to conﬁrm the diagnosis and provide the tumour
grade from small tissue samples is also essential. It should
be stressed that biopsy does have associated problems. It is
painful, expensive and the biopsy tract requires excision at
the time of operation [27, 28]. Therefore when diagnosis and
management are not in doubt, biopsy may be avoided.
In our centre, the accuracy of exact histological grading
of long bone chondrosarcoma based on image guided needle
biopsy was 86% (67/78 cases). However, when classed
clinically as either low or high grade, the accuracy was
close to 94% (73/78). Grading into these two signiﬁcant
diﬀerent clinical entities is critical and more important
than the exact histological grade, as the treatment regimen
for low- and high-grade tumours may markedly diﬀer.International Journal of Surgical Oncology 3
Table 1: Summary of case histories, histology diagnosis, and management of patients with discrepancy in histological grade (F: femur; H:
humerus).
Case Gender Age Bone Pre-op biopsy Excision biopsy Surgery Local recurrence
1M a l e 3 0 F Low-grade (II) High-grade (III) Excision No
2M a l e 2 4 F High-grade
(I-II-III) Low-grade (I-II) Curettage with
bone cement
No
3F e m a l e 7 7H Low-grade (II) High-grade
(I-II-III) Excision No
4F e m a l e 5 4F Low-grade (II) Low-grade (I) Excision No
5F e m a l e 1 0F Chondroblastic
osteosarcoma
High-grade
chondrosarcoma
(III)
Excision No
6M a l e 6 5 F Low-grade (I) Low-grade (I-II) Excision No
7M a l e 5 1 HLow-grade (II) High-grade (II-III) Excision No
8F e m a l e 5 0F Low-grade (I) Low-grade (I-II) Excision No
9M a l e 2 8 F Low-grade (I) High-grade (II-III) Excision No
10 Male 63 F High-grade (III) Dediﬀerentiated
chondrosarcoma Excision No
11 Female 20 F Low-grade (I) Low-grade (I-II) Excision No
Undergrading of tumours may lead to inadequate surgical
treatment and increased risk of local recurrence, metastases
and subsequent mortality. Overgrading of tumours could
bring about inappropriate use of more invasive surgical
treatmentswiththeincreasedrisksofsurgicalcomplications,
psychologicalmorbidity,lossoffunction,andpoorcosmesis.
On review of the surgical histology, all 78 cases that
underwentpre-operativeneedlebiopsyreceivedanappropri-
atesurgicalintervention.Inallcasesthegradingoftheneedle
biopsy was critical in determining the treatment plan. The
67 cases where the exact grade of the tumour was correctly
identiﬁed from the needle biopsy, all received an appropriate
surgical intervention. In the 11 cases where there was a
mismatch between the needle biopsy and excision specimen
histological grading, no inappropriate surgical intervention
occurred. The mismatch in only ﬁve of these 11 cases meant
a reclassiﬁcation from low grade to high grade. Ten of
these tumours were excised primarily and one was treated
by curettage with bone cement (this case was ultimately
classiﬁed as low grade). None of these cases required any
subsequent surgical procedures related to their chondrosar-
coma. We attribute this successful decision-making to the
multidisciplinary approach used. This includes a team of
experienced orthopaedic oncology surgeons, radiologists
and pathologists, which greatly assists in pre-operative diag-
nosis and planning. In two of the cases, the histological grade
of the needle biopsy overestimated the grade of the tumour.
Surgical excision of one of these lesions was undertaken,
and the remaining tumour was treated by curettage with
bone cement. Both cases are under careful observation
with clinical examination and further imaging at regular
intervals. For the remaining nine mismatched cases where
the needle biopsy suggested a lower-grade diagnosis than the
subsequent excision histology revealed, the multidisciplinary
team concluded during pre-operative surgical planning that
allshouldsubsequentlyundergosurgicalexcisionratherthan
curettage with bone cement. In these cases, the treatment
decision to err on the side of caution was taken on the
basis of the history, clinical examination, and radiographic
ﬁndings speciﬁc to each individual patient as well as the
histopathological features. Again, we consider this successful
decision making to be a result of discussion between an
experienced multidisciplinary team.
We restricted our study to chondrosarcoma of the femur,
tibia, and humerus, excluding those tumours occurring
in other locations. Such other tumours, particularly those
occurring within the pelvis or axial skeleton, may be subject
to diﬀering treatment options. Whilst a needle biopsy is still
essential in accurately diagnosing the tumour grade, these
lesions may be treated diﬀerently to their counterparts of
identical grade in the long bones that we have included in
our study, and direct comparison therefore should be looked
upon cautiously.
The most likely explanation for the mismatches in
grading that we identiﬁed is the well-described heterogeneity
of chondrosarcoma lesions and the incumbent sampling
diﬃculties related to this. In the cases where the tumour
grade was underestimated, it is likely that the tissue sampled
by these needle biopsies represented lower-grade segments
of the lesions without sampling the more malignant parts.
The reason for the two overestimate discrepancies is unclear,
but such cases highlight the potential intra- and interob-
serverdiﬃcultiesofchondrosarcomagradeclassiﬁcation.We
accept that the mismatches could be explained by human
error in interpretation of the specimens at a pathological
level, or suboptimal biopsy tissue samples. It is clear that an
adequatebiopsytissuesampleisessentialtomakeanaccurate
diagnosis.
We conclude that accurate image-guided biopsy is a
very useful adjunct in determining the histological grade
of chondrosarcoma and the subsequent treatment plan.
At present, a multidisciplinary approach oﬀers the most4 International Journal of Surgical Oncology
reliable means of accurately diagnosing and grading of
chondrosarcoma of long bones.
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